RWD54 Real-World Evidence for Patient Outcomes and Mutational Burden in Non-Small Cell Lung (NSCLC) Cancer Patients in England Using EGFR Biomarker Test Data from Routine Clinical Care
Sophie C. Hagenaars(IQVIA (United Kingdom)), Valeria Lascano(Center for Translational Molecular Medicine), Sarah Benson(University of Regina), Fiona C. Ingleby(MRC Clinical Trials Unit at UCL), A. Lambova, Sophie José(NHS England), J Gaultney(IQVIA (United Kingdom)), Mounika Parimi(IQVIA (United Kingdom)), L. Frayling(Insight Healthcare), Maha Muwaffak(IQVIA (United Kingdom)), Jasmine Huynh(Tufts University)
Cited by 1
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
|Journal of Hepatology|2015|172
Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
|The Journal of Infectious Diseases|2014|102